(NASDAQ: GNFT) Genfit Sa's forecast annual revenue growth rate of -2.57% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.22%.
Genfit Sa's revenue in 2025 is $80,612,500.On average, 1 Wall Street analysts forecast GNFT's revenue for 2025 to be $3,460,515,531, with the lowest GNFT revenue forecast at $3,460,515,531, and the highest GNFT revenue forecast at $3,460,515,531. On average, 1 Wall Street analysts forecast GNFT's revenue for 2026 to be $3,906,180,424, with the lowest GNFT revenue forecast at $3,906,180,424, and the highest GNFT revenue forecast at $3,906,180,424.
In 2027, GNFT is forecast to generate $3,595,263,035 in revenue, with the lowest revenue forecast at $3,595,263,035 and the highest revenue forecast at $3,595,263,035.